Business
Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months
CHICAGO, IL / ACCESS Newswire / May 11, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced it is projecting Fort18™to generate over $3.2 million ...
About this update from Cosmos Health Inc.
[{"type":"text","content":"CHICAGO, IL / ACCESS Newswire / May 11, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced it is projecting Fort18™ to generate over $3.2 million in incremental annual U.S. revenue within the next 12 to 18 months, based on its current commercialization strategy and internal assumptions.","length":410,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1200,"height":896,"url":"https://media.zenfs.com/en/accesswire.ca/68abb1bb639764c4dc79ea406a8e5944"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5lh8ytq1gsCT7ISzKzhIvg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTcxNw--/https://media.zenfs.com/en/accesswire.ca/68abb1bb639764c4dc79ea406a8e5944","width":960,"height":717},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/LdG.Wl4v2ViUGIZUdbP36Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQ3OA--/https://media.zenfs.com/en/accesswire.ca/68abb1bb639764c4dc79ea406a8e5944","width":640,"height":478},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/t8MemKI5a3lo812MJd5orw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xNzky/https://media.zenfs.com/en/accesswire.ca/68abb1bb639764c4dc79ea406a8e5944","width":1200,"height":896}},"href":"https://app.accessnewswire.com/imagelibrary/bd2d994b-c38b-46fa-a4c0-c28112fc9986/1165776/fort18.jpeg","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Fort18™ is the latest addition to the Company's "18 Series," a growing portfolio of science-based nutraceutical products. Formulated with a proprietary botanical blend evaluated in published clinical research, Fort18™ enters the U.S. sexual health supplement category targeting men's sexual stamina and endurance. The product is expected to launch commercially in June 2026.","length":392,"tagName":"p"},{"type":"text","content":"The Company's projection is underpinned by a staged rollout beginning with direct-to-consumer e-commerce, with planned expansion into selected retail channels over time. The forecast incorporates internal assumptions around pricing, anticipated sales volumes, repeat purchase behavior, and distribution growth, and remains subject to the continued execution of the Company's commer...